(Q44117880)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200701%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Long-term results (12 years) of high-dose therapy in 127 patients with de novo multiple myeloma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200701%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200701%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

Moreau P

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200701%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Misbahi R

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200701%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Morineau N

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200701%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Mahé B

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200701%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Vigier M

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200701%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Rapp MJ

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200701%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Bataille R

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200701%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Harousseau JL

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200701%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

language of work or name

1 reference

1 September 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200701%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200701%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200701%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200701%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

1838-1843

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200701%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402613

12 November 2019

exact match

0 references

cites work

High-dose intravenous melphalan for plasma-cell leukaemia and myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402613

7 January 2021

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402613

7 January 2021

High-dose melphalan for multiple myeloma: long-term follow-up data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402613

7 January 2021

Long-term follow-up after high-dose therapy for high-risk multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402613

7 January 2021

Prolonged survival after intensive therapy and purged ABMT in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402613

7 January 2021

Effective treatment of advanced multiple myeloma refractory to alkylating agents.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402613

7 January 2021

Multiple myeloma: VMCP/VBAP alternating combination chemotherapy is not superior to melphalan and prednisone even in high-risk patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402613

7 January 2021

Prospective randomized placebo-controlled study of granulocyte-macrophage colony-stimulating factor without stem-cell transplantation after high-dose melphalan in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402613

7 January 2021

Melphalan 220 mg/m2 followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402613

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402613

7 January 2021

Asymptotically Efficient Rank Invariant Test Procedures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402613

7 January 2021

Invasive Aspergillosis as an Opportunistic Infection in Nonallografted Patients with Multiple Myeloma: A European Organization for Research and Treatment of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402613

7 January 2021

Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983-93 and 1994-98 at European Group for Blood and Marrow Transplantation centres

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402613

7 January 2021